Yesterday, March 9, 2016, 100 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $6.95 to $910,998,000.00.

Highlighted Stocks Traded by Insiders:

HMS Holdings (HMSY) - FREE Research Report

Neuman Semone, who is EVP, Operations at HMS Holdings, sold 7,992 shares at $14.25 on March 9, 2016. Following this transaction, the EVP, Operations owned 113,254 shares meaning that the stake was reduced by 6.59% with the 7,992-share transaction.

The shares most recently traded at $13.37, down $0.88, or 6.58% since the insider transaction. Historical insider transactions for HMS Holdings go as follows:

  • 4-Week # shares bought: 2,000
  • 4-Week # shares sold: 59,000
  • 12-Week # shares bought: 2,000
  • 12-Week # shares sold: 59,000
  • 24-Week # shares bought: 2,000
  • 24-Week # shares sold: 111,812

The average volume for HMS Holdings has been 704,400 shares per day over the past 30 days. HMS Holdings has a market cap of $1.2 billion and is part of the services sector and diversified services industry. Shares are up 10.45% year-to-date as of the close of trading on Wednesday.

HMS Holdings Corp., through its subsidiaries, provides healthcare insurance benefit cost containment services in the United States. The company has a P/E ratio of 49.5. Currently, there are 7 analysts who rate HMS Holdings a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on HMSY - FREE

TheStreet Quant Ratings

rates HMS Holdings as a

hold

. The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, compelling growth in net income and revenue growth. However, as a counter to these strengths, we find that the stock has had a generally disappointing performance in the past year. Get the full

HMS Holdings Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

TriMas (TRS) - FREE Research Report

Gougarty Nancy, who is Director at TriMas, sold 4,005 shares at $17.61 on March 9, 2016. Following this transaction, the Director owned 14,817 shares meaning that the stake was reduced by 21.28% with the 4,005-share transaction.

The shares most recently traded at $17.26, down $0.35, or 2.03% since the insider transaction. Historical insider transactions for TriMas go as follows:

  • 4-Week # shares bought: 2,500
  • 4-Week # shares sold: 36,183
  • 12-Week # shares bought: 2,500
  • 12-Week # shares sold: 36,183
  • 24-Week # shares bought: 2,500
  • 24-Week # shares sold: 36,183

The average volume for TriMas has been 278,000 shares per day over the past 30 days. TriMas has a market cap of $812.8 million and is part of the industrial goods sector and industrial industry. Shares are down 5.25% year-to-date as of the close of trading on Wednesday.

TriMas Corporation designs, manufactures, and distributes engineered and applied products for commercial, industrial, and consumer markets worldwide. It operates through four segments: Packaging, Aerospace, Energy, and Engineered Components. Currently, there are 2 analysts who rate TriMas a buy, no analysts rate it a sell, and 7 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on TRS - FREE

TheStreet Quant Ratings

rates TriMas as a

sell

. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, disappointing return on equity, poor profit margins, weak operating cash flow and generally disappointing historical performance in the stock itself. Get the full

TriMas Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Hydrogenics (HYGS) - FREE Research Report

CommScope, Inc. of North Carolina, who is 10% Owner at Hydrogenics, sold 16,149 shares at $8.30 on March 9, 2016. Following this transaction, the 10% Owner owned 1.3 million shares meaning that the stake was reduced by 1.21% with the 16,149-share transaction.

The shares most recently traded at $7.68, down $0.62, or 8.05% since the insider transaction. Historical insider transactions for Hydrogenics go as follows:

  • 4-Week # shares sold: 29,443
  • 12-Week # shares sold: 29,443
  • 24-Week # shares sold: 29,443

The average volume for Hydrogenics has been 74,500 shares per day over the past 30 days. Hydrogenics has a market cap of $86.1 million and is part of the industrial goods sector and industrial industry. Shares are down 6.5% year-to-date as of the close of trading on Wednesday.

Hydrogenics Corporation, together with its subsidiaries, designs, develops, and manufactures hydrogen generation products based on water electrolysis technology; and fuel cell products based on proton exchange membrane technology. Currently, there are 3 analysts who rate Hydrogenics a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on HYGS - FREE

TheStreet Quant Ratings

rates Hydrogenics as a

sell

. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, generally high debt management risk, disappointing return on equity, poor profit margins and generally disappointing historical performance in the stock itself. Get the full

Hydrogenics Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.